The equipment installation of Hubei Xindesheng Huanggang New Factory has been successfully completed, and the intelligen

Hubei Xindesheng Material Technology Co., Ltd.'s Huanggang New Production Base Construction Another Good News - As of now, all production equipment in the new factory has been installed in place, and key processes such as flaw detection, pressure leakage testing, and single machine debugging have been completed and accepted. The automatic control system joint debugging and testing will be fully completed. The project is steadily advancing with high standards and high quality, and is expected to officially enter the trial production stage in the near future.

Huanggang New Factory is the second R&D and production base established by Hubei Xindesheng Material Technology Co., Ltd. after the Gedian base. The project covers an area of approximately 80 acres. After the new factory is fully completed and put into operation, the company's total production capacity will double, providing a solid guarantee for the large-scale and high-quality production of core products such as biological buffering agents and carbomers.

The equipment installation has been fully completed and the key processes have been passed

All production equipment installation is in place. All production equipment in the new factory, including customized large reaction vessels, distillation towers, drying equipment, packaging lines, etc., have been installed and fixed. The equipment selection fully considers the strict requirements of biological buffer products for high purity, low impurities, and batch consistency. The core equipment is customized design, which can meet the flexible production needs of multiple product lines such as Tris, Hepes,caps, mops, carbomer, and blood separation gel.

Flaw detection, pressure leakage testing, and single machine debugging passed all at once. After the equipment installation was completed, the project team strictly followed the chemical project construction specifications and completed three key inspection processes in sequence:

Ultrasonic testing: Conduct non-destructive testing on all pressure vessels and pressure pipelines, and ensure that all welds meet the quality standards;

Pressure testing and leak detection: Conduct pressure testing and leak detection on the entire system, and ensure that the airtightness meets the design standards;

Single machine debugging: Each device completes no-load and load tests separately, and all operating parameters meet the standards.

The successful acceptance of the three major processes marks that the hardware facilities of the new factory have fully met the conditions for joint testing.

The self-control system is about to complete the comprehensive upgrade of intelligent manufacturing through joint debugging

All hardware installations of the self-control system have been completed. The automation control system of the new factory covers the complete production chain from raw material storage, precise feeding, reaction process control, temperature and pressure regulation to finished product packaging and delivery. The installation and wiring of all self-control equipment have been completed.

The joint debugging and testing are about to end. At present, the joint debugging and testing of the self-control system has entered the final stage. After the joint debugging is completed, the entire production line will achieve full process automation operation, and operators can complete real-time monitoring and precise adjustment of the entire production process in the central control room.

The construction of intelligent production lines will bring three major improvements:

One is to improve efficiency. Automated control significantly reduces manual intervention, resulting in a more stable and efficient production rhythm.

The second is the improvement of quality. Accurate process control effectively reduces fluctuations between batches, ensuring product consistency.

The third is to enhance safety. The system has complete abnormal alarm and interlock protection functions, which can monitor key parameters such as temperature, pressure, and liquid level in real time, automatically handle abnormalities, and effectively prevent safety risks.

The countdown to trial production is approaching, and the release of production capacity is just around the corner

With the comprehensive completion of equipment installation and automatic control system debugging, the trial production of the new factory has entered the countdown stage.

The trial production plan covers the entire process operation specifications, process parameter settings, quality control standards, safety emergency plans, and personnel training plans for feeding and testing. The remaining finishing work is expected to be completed in the near future.

After the project is put into operation, the company will form a dual base collaborative production pattern of Gedian and Huanggang, and the total production capacity will achieve a leapfrog increase. The annual production capacity of 5000 tons can fully meet the sustained growth demand for high-end biological buffering agents in domestic and international markets.

Continuously empowering the industry to assist in localization substitution

Biological buffering agents are essential core materials for strategic emerging industries such as in vitro diagnostics (IVD), biopharmaceuticals, and new energy. For a long time, the high-end biological buffer market has relied to some extent on imports. The completion and operation of Hubei Xindesheng Huanggang New Factory will effectively enhance the independent supply capacity of domestic biological buffering agents.

After the new factory is put into operation, the company's biological buffer product matrix will be further enriched, with a stable purity of over 99%, and customized indicators can be achieved according to customer application scenarios. The improvement of large-scale production capacity will also provide customers with more stable and efficient supply chain guarantees.

In the future, Hubei Xindesheng Material Technology Co., Ltd. will continue to deepen its cultivation in the fields of biological buffering agents and IVD core raw materials, and continue to empower industry development with higher quality products and more professional services.